Basic Information | Post buying leads | Suppliers | Cas Database |
Name |
ZOMEPIRAC SODIUM |
EINECS | 264-669-2 |
CAS No. | 64092-48-4 | Density | N/A |
PSA | 62.13000 | LogP | 1.51030 |
Solubility | N/A | Melting Point |
N/A |
Formula | C15H14 Cl N O3 . Na | Boiling Point | 470.8°C at 760 mmHg |
Molecular Weight | 313.716 | Flash Point | 238.5°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion. Human systemic effects by ingestion: cyanosis. When heated to decomposition it emits toxic fumes of Cl−, Na2O, and NOx. | Risk Codes | 23/24/25 |
Molecular Structure | Hazard Symbols | T | |
Synonyms |
1H-Pyrrole-2-aceticacid, 5-(4-chlorobenzoyl)-1,4-dimethyl-, sodium salt (9CI);McN 2783-21-98;Sodium zomepirac;Zomax;Zomepirac sodium;Zomepirac sodium salt; |
Article Data | 1 |
Product Name: Zomepirac sodium (CAS NO.64092-48-4)
Molecular Formula: C15H13ClNNaO3
Molecular Weight: 313.71g/mol
Mol File: 64092-48-4.mol
Einecs: 264-669-2
Boiling point: 470.8 °C at 760 mmHg
Flash Point: 238.5 °C
Enthalpy of Vaporization: 77.26 kJ/mol
Vapour Pressure: 1.15E-09 mmHg at 25°C
H-Bond Donor: 0
H-Bond Acceptor: 3
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | > 100mg/kg (100mg/kg) | Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 250, 1982. | |
hamster | LD50 | oral | 743mg/kg (743mg/kg) | Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 250, 1982. | |
man | TDLo | oral | 1429ug/kg (1.429mg/kg) | LUNGS, THORAX, OR RESPIRATION: CYANOSIS | Annals of Allergy. Vol. 48, Pg. 233, 1982. |
mouse | LD50 | oral | 63mg/kg (63mg/kg) | Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 250, 1982. | |
rat | LD50 | oral | 27mg/kg (27mg/kg) | Drugs. International Journal of Current Therapeutics and Applied Pharmacology Reviews. Vol. 23, Pg. 250, 1982. | |
women | LDLo | oral | 117mg/kg (117mg/kg) | BEHAVIORAL: COMA CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Journal of Analytical Toxicology. Vol. 7, Pg. 223, 1983. |
women | TDLo | oral | 16mg/kg/2D-I (16mg/kg) | KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | Archives of Internal Medicine. Vol. 143, Pg. 1171, 1983. |
women | TDLo | oral | 70mg/kg/10D-I (70mg/kg) | GASTROINTESTINAL: NAUSEA OR VOMITING KIDNEY, URETER, AND BLADDER: "CHANGES IN TUBULES (INCLUDING ACUTE RENAL FAILURE, ACUTE TUBULAR NECROSIS)" | American Journal of Medicine. Vol. 76, Pg. 1113, 1984. |
Safety Information of Zomepirac sodium (CAS NO.64092-48-4):
Hazard Codes: T
Risk Statements: 23/24/25
23: Toxic by inhalation
24: Toxic in contact with skin
25: Toxic if swallowed
Safety Statements: 22-36/37/39-45
22: Do not breathe dust
36: Wear suitable protective clothing
37: Wear suitable gloves
39: Wear eye/face protection
45: In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
Zomepirac sodium ,its CAS NO. is 64092-48-4,the synonyms is 1h-Pyrrole-2-aceticacid,5-(4-chlorobenzoyl)-1,4-dimethyl-,sodiumsalt,dihyd ; 5-(4-Chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-aceticacidsodiumsaltdihydra ; Mcn2783-21-98 ; Sodium5-(4-chlorobenzoyl)-1,4-dimethyl-1h-pyrrole-2-acetatedihydrate ; Sodiumzomepirac ; Zomax ; Zomepiracsodium ; Zomepirac sodium salt .